<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-044537</identifier>
<setSpec>0210-4806</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Antimicrobial susceptibility of escherichia coli isolated from bacteriurias in Bierzo Health Area during 2003</dc:title>
<dc:description xml:lang="en">OBJECTIVE: Sensitivity to antibiotics of Escherichia coli isolated from intrahospital and extrahospital bacteriurias is analized.         MATERIAL AND METHODS: Sensitivity to nineteen antibiotics used in the clinical practise was determined in strains of Escherichia coli isolated from intrahospital and extrahospital bacteriurias.         RESULTS: The prevalence of in-vitro susceptibilities to antibiotics were (hospital, state health service clinic, health center-primary-care): imipenem (100%-100%-100%; p=NS), amikacin (100%-100%-99.7%; p=NS), fosfomicyn (98.6%- 98.4%-99.6%; p=NS), cefepime (96%-96.9%-98.3%; p=NS), piperacillin-tazobactam (96%-95.3%-96.6%; p=NS), aztreonam (93.5%-94.7%-97.7%; p&lt;0.001), ceftazidime (93.5%-94.3%-97.8%; p&lt;0.001), cefotaxime (93.1%-95%-97.7%; p&lt;0.001), cefixime (92.7%-94.6%-96.7%; p&lt;0.05), nitrofurantoin (92%-94.7%-94.7%; p=NS), cefuroxime (88.4%-93.1%- 95%; p&lt;0.001), amoxicillin-clavulanic (87.7%-88.7%-93.8%; p&lt;0.001), tobramicyn (87%-93.7%-93.8%; p&lt;0.001), gentamcin (85.9%-92.8%-93%; p&lt;0.001), cefazolin (84.4%-88.7%-91.6%; p&lt;0.01), ciprofloxacin (63.8%-71.4%-78.4%; p&lt;0.001), norfloxacin (63%-70.8%-78.2%; p&lt;0.001), cotrimoxazole (65.2%-68.6%-74.9%; p&lt;0.01) and ampicillin (35.5%-42.5%-47.8%; p&lt;0.01). (*NS= No significant differences).         CONCLUSIONS: The knowledge of the sensitivity of uropathogens to antimicrobians can allow us to initiate empirical therapy of urinary tract infections</dc:description>
<dc:creator>López Medrano, R</dc:creator>
<dc:creator>Sánchez Merino, J. M</dc:creator>
<dc:creator>Jiménez Rodríguez, M</dc:creator>
<dc:creator>Guillán Maquieira, C</dc:creator>
<dc:creator>Fuster Foz, C</dc:creator>
<dc:creator>García Alonso, J</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">OBJETIVO: Evaluar la sensibilidad a varios antibióticos en cepas de Escherichia coli aisladas en muestras de orina de pacientes hospitalarios y extrahospitalarios.         MATERIAL Y MÉTODOS: Se analizaron los urocultivos positivos para Escherichia coli obtenidos de muestras de pacientes hospitalizados y atendidos en consultas externas hospitalarias y atención primaria. Se determinó la sensibilidad de este germen a diecinueve antibióticos de uso hospitalario y/o extrahospitalario.         RESULTADOS: Según el origen hospitalario, consultas externas hospitalarias y atención primaria, respectivamente, la sensibilidad in vitro ha sido la siguiente: imipenem (100%, 100% y 100%; p=NS), amikacina (100%, 100% y 99,7%; p=NS), fosfomicina (98,6%, 98,4% y 99,6%; p=NS), cefepima (96%, 96,9% y 98,3%; p=NS), piperacilina-tazobactam (96%, 95,3% y 96,6%; p=NS), aztreonam (93,5%, 94,7% y 97,7%; p&lt;0,001), ceftazidima (93,5%, 94,3% y 97,8%; p&lt;0,001), cefotaxima (93,1%, 95% y 97,7%; p&lt;0,001), cefixima (92,7%, 94,6% y 96,7%; p&lt;0,05), nitrofurantoína (92%, 94,7% y 94,7%; p=NS), cefuroxima (88,4%, 93,1% y 95%; p&lt;0,001), amoxicilina-clavulánico (87,7%, 88,7% y 93,8%; p&lt;0,001), tobramicina (87%, 93,7% y 93,8%; p&lt;0,001), gentamicina (85,9%, 92,8% y 93%; p&lt;0,001), cefazolina (84,4%, 88,7% y 91,6%; p&lt;0,01), ciprofloxacino (63,8%, 71,4%, 78,4%; p&lt;0,001), norfloxacino (63%, 70,8 y 78,2%; p&lt;0,001), cotrimoxazol (65,2%, 68,6% y 74,9%; p&lt;0,01) y ampicilina (35,5%, 42,5% y 47,8%; p&lt;0,01). (NS= No significativo).         CONCLUSIONES: El tratamiento de las infecciones del tracto urinario frecuentemente se inicia de forma empírica. Por este motivo resulta esencial conocer los patrones de sensibilidad de las bacterias potencialmente causantes del cuadro</dc:description>
<dc:source>Actas Urol Esp;28(8): 588-593, sept. 2004. tab</dc:source>
<dc:identifier>ibc-044537</dc:identifier>
<dc:title xml:lang="es">Sensibilidad microbiana de escherichia coli en bacteriurias en el área sanitaria del Bierzo en el año 2003</dc:title>
<dc:subject>^d5016^s22001</dc:subject>
<dc:subject>^d14952^s22016</dc:subject>
<dc:subject>^d28477^s22012</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d33878</dc:subject>
<dc:subject>^d^s22031</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29310</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d21044</dc:subject>
<dc:subject>^d28477^s22016</dc:subject>
<dc:subject>^d24244^s22074</dc:subject>
<dc:subject>^d^s22038</dc:subject>
<dc:subject>^d24244^s22066</dc:subject>
<dc:subject>^d24244^s22045</dc:subject>
<dc:subject>^d911^s22002</dc:subject>
<dc:subject>^d911^s22073</dc:subject>
<dc:subject>^d28477^s22050</dc:subject>
<dc:subject>^d19042</dc:subject>
<dc:type>article</dc:type>
<dc:date>200409</dc:date>
</metadata>
</record>
</ibecs-document>
